A meta-analysis into the mediatory effects of family planning utilization on complications of pregnancy in women of reproductive age
- PMID: 38498424
- PMCID: PMC10947693
- DOI: 10.1371/journal.pone.0294475
A meta-analysis into the mediatory effects of family planning utilization on complications of pregnancy in women of reproductive age
Abstract
Background: Despite conflicting findings in the current literature regarding the correlation between contraceptives and maternal health consequences, statistical analyses indicate that family planning may decrease the occurrence of such outcomes. Consequently, it is crucial to assess the capability of family planning to mitigate adverse maternal health outcomes.
Objectives: This review investigates the effects of modern contraceptive use on maternal health.
Search methods: This systematic review is registered on Prospero (CRD42022332783). We searched numerous databases with an upper date limit of February 2022 and no geographical boundaries.
Selection criteria: We included observational studies, including cross-sectional, cohort, case-control studies, and non-RCT with a comparison group. We excluded systematic reviews, scoping reviews, narrative reviews, and meta-analyses from the body of this review.
Main results: The review included nineteen studies, with five studies reporting a reduction in maternal mortality linked to increased access to family planning resources and contraceptive use. Another three studies examined the impact of contraception on the risk of preeclampsia and our analysis found that preeclampsia risk was lower by approximately 6% among contraceptive users (95% CI 0.82-1.13) compared to non-users. Two studies assessed the effect of hormonal contraceptives on postpartum glucose tolerance and found that low-androgen contraception was associated with a reduced risk of gestational diabetes (OR 0.84, 95% CI 0.58-1.22), while DMPA injection was possibly linked to a higher risk of falling glucose status postpartum (OR 1.42, 95% CI 0.85-2.36). Two studies evaluated high-risk pregnancies and births in contraceptive users versus non-users, with the risk ratio being 30% lower among contraceptive users of any form (95% CI 0.61, 0.80). None of these results were statistically significant except the latter. In terms of adverse maternal health outcomes, certain contraceptives were found to be associated with ectopic pregnancy and pregnancy-related venous thromboembolism through additional analysis.
Copyright: © 2024 Jahanfar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.Cochrane Database Syst Rev. 2019 Apr 23;4(4):CD004317. doi: 10.1002/14651858.CD004317.pub5. Cochrane Database Syst Rev. 2019. PMID: 31013349 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.Cochrane Database Syst Rev. 2023 May 15;5(5):CD014908. doi: 10.1002/14651858.CD014908.pub3. Cochrane Database Syst Rev. 2023. PMID: 37184292 Free PMC article. Review.
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
-
Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Epub 2016 Feb 26. J Obstet Gynaecol Can. 2016. PMID: 27032746 English, French.
Cited by
-
Comment on "Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis".Mol Diagn Ther. 2024 May;28(3):345-346. doi: 10.1007/s40291-024-00707-z. Epub 2024 Apr 10. Mol Diagn Ther. 2024. PMID: 38600343 No abstract available.
-
Navigating norms: a qualitative exploration of factors shaping contraceptive use in Senegal.Front Glob Womens Health. 2025 Jul 28;6:1527733. doi: 10.3389/fgwh.2025.1527733. eCollection 2025. Front Glob Womens Health. 2025. PMID: 40792049 Free PMC article.
References
-
- “Unmet Need for Contraception: Fact Sheet.” PRB, https://www.prb.org/resources/unmet-need-for-contraception-fact-sheet/. Accessed 16 Oct. 2022.
-
- Sedgh, Gilda, et al. Unmet Need for Contraception in Developing Countries: Examining Women’s Reasons for Not Using a Method. June 2016. www.guttmacher.org, https://www.guttmacher.org/report/unmet-need-for-contraception-in-develo....
-
- World Health Organization, 2023. Maternal mortality. [cited 2023 Nov 10]. Available from: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality.
-
- Ahmed Saifuddin, et al.. “Maternal Deaths Averted by Contraceptive Use: An Analysis of 172 Countries.” The Lancet, vol. 380, no. 9837, July 2012, pp. 111–25. www.thelancet.com, doi: 10.1016/S0140-6736(12)60478-4 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical